Cyteir Therapeutics

+$0.21 (+11.86%) Today
+$0.05 (+2.53%) As of 9:33 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYT and other ETFs, options, and stocks.

About CYT

Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies.

CEO
Markus F. Renschler
Employees
40
Headquarters
Lexington, Massachusetts
Founded
2012

CYT Key Statistics

Market cap
70.11M
Price-Earnings ratio
—
Dividend yield
—
Average volume
474.50K
High today
$2.04
Low today
$1.75
Open price
$1.80
Volume
422.78K
52 Week high
$23.10
52 Week low
$1.56

CYT Earnings

-$4.83
-$3.22
-$1.61
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.40 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure